In situ apoptosis in the thyroid

Thyroid

Volumn 10, Issue 2, 2000, Pages 117-122

  Sreelekha, T T ^a   Pradeep, V M ^a   Vijayalakshmi, K ^b   Belthazar, Anni ^b   Chellam, V G ^b   Nair, M Balaraman ^c   Pillai, M Radhakrishna ^a  

^a REGIONAL CANCER CENTRE   (India)

^b Medical College Hospital Thiruvananthapuram   (India)

^c Doctors Diagn and Research Centre   (India)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; PROTEIN BCL 2; PROTEIN P53;

ANTIGEN EXPRESSION; APOPTOSIS; ARTICLE; CELL PROLIFERATION; HUMAN; HUMAN TISSUE; NICK END LABELING; PRIORITY JOURNAL; THYROID CARCINOMA; THYROID MEDULLARY CARCINOMA; TUMOR GROWTH;

EID: 0034004296     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2000.10.117     Document Type: Article

References (28)

1. Dobashi Y, Sakamoto A, Sugimura H, Mernyei M, Mori M, Oyama T, Machinami R 1993 Over expression of p53 as a possible prognostic factor in human thyroid carcinoma. Am J Surg Pathol 17:375-381.
2. Donghi R, Longoni A, Pilotti S, Michieli P, Della Porta G, Pierotti MA 1993 Gene p53 mutations are restricted to poorly differentiated and undifferentiated carcinoma of the thyroid gland. J Clin Invest 91:1753-1760.
3. Pilotti S, Collini P, Rike F, Cattoretti G, Del Bo R, Pierotti MA 1994 Bcl-2 protein expression in carcinomas originating from the follicular epithelium of the thyroid gland. J Pathol 172:337-342.
4. Korsmeyer SJ 1992 bcl-2: an antidote to programmed cell death. Cancer Surveys 15:105-118.
5. Lu Q, Abel P, Foster CS, Lalani E 1996 bcl-2: role in epithelial differentiation and oncogenesis. Hum Pathol 27:102-110.
6. Wang Y, Szekely L, Okan I, Klein G, Wiman KG 1993 Wild-type p53 triggered apoptosis is inhibited by bcl-2 in a v-myc induced T-cell lymphoma line. Oncogene 8:3427-3431.
7. Pillai MR, Kesari AL, Chellam VG, Madhavan J, Nair MK 1998 Spontaneous programmed cell death in infiltrating duct carcinoma: Association with p53, bcl-2, tumor proliferation and hormone receptor status. Pathol Res Pract 194:549-557.
8. Davidoff AM, Humprey PA, Iglehart JD, Marks JR 1991 Genetic basis for p53 overexpression in human breast cancer. Proc Natl Acad Sci USA 88:5066-5011.
9. Deppert W 1994 The yin and yang of p53 in cellular proliferation. Semin Cancer Biol 5:187-202.
10. Martinez J, Georgoff I, Martinez J 1991 Cellular localization and cell cycle regulation by a temperature sensitive p53 protein. Genes Dev 5:151-159.
11. O'Neill AJ, Staunton MJ, Gaffney EF 1996 Apoptosis occurs independently of bcl-2 and p53 overexpression in non small cell lung carcinoma. Histopathology 29:5-50.
12. Halder S, Negrini M, Monne M, Sabbioni S, Croce CM 1994 Down regulation of bcl-2 and p53 in breast cancer cells. Cancer Res 54:2095-2097.
13. McDonnel, Martin TJ, Brisbay MC, McConnel K, Tu S, Cambell M 1993 The bcl-2 oncogene, Apoptosis and neoplasia. Radiat Res 136:307-310.
14. Chan JKC 1995 Tumor of the thyroid and parathyroid glands. In: Fletcher CDM (ed) Diagnostic Histopathology of Tumors. Churchill Livingstone, New York, 705-764.
15. Ellis PA, Smith IE, Dowsett M 1996 Apoptosis - Its role in tumor growth and therapy. Cytopathology 22:132-135.
16. Kesari AL, Chellam VG, Nair PP, Ahmed I, Madhavan J, Thomas PA 1997 p53 tumor suppressor protein and tissue proliferative fraction in infiltrating duct carcinoma. J Surg Oncol 65:159-163.
17. Martinez J, Georgoff I, Martinez J 1991 Cellular localization and cell cycle regulation by a temperature sensitive p53 protein. Genes Dev 5:151-159.
18. Ravi D, Ramdas K, Mathew BS, Nalinakumari KR, Nair MK 1998 Angiogenesis during tumor progression in the oral cavity is related to reduced apoptosis and high tumor cell proliferation. Eur J Cancer Part II, Oral Oncol 34:543-548.
19. Srinivas G, Kusumakumari P, Nair MK, Panicker KR, Pillai MR 1997 Tumor proliferative compartment, multidrug resistant gene product and apoptosis regulatory p53 and bcl-2 proteins in paediatric acute lymphoblastic leukemia. Oncol Rep 4:1083-1087.
20. Miyashita T, Harigari M, Hanada M, Reed JC 1994 Identification of a p53 dependent negative response element in the bcl-2 gene. Cancer Res 54:3131-3135.
21. Moore D, Fianko DO, Garcia B, Chakrabarthi S 1998 Apoptosis in thyroid neoplasms: relationship with p53 and bcl-2 expression. Histopathology 32:35-42.
22. Salvakumaran M, Lin HK, Miyashita T, Wang HG, Krayewski S, Reed JC 1994 Immediate early up regulation of bax expression by p53 but not TGF beta 1: A paradigm for distant apoptotic pathways. Oncogene 9:1791-1798.
23. Diebold J, Barelton G, Felchner M, Meier W, Dopfer K, Schmidt M 1996 Bcl-2 expression, p53 accumulation and apoptosis in ovarian carcinomas. Am J Clin Pathol 105: 341-349.
24. Merkle C, Fritsche M, Mundt M, Jahne R, Groner B 1998 Transcriptional regulation and induction of apoptosis: Implications for the use of monomeric p53 variants in gene therapy. Gene Ther 5:1631-1641.
25. Haupt Y, Rowan S, Shaulian E, Vousden KH, Oren M 1995 Induction of apoptosis in He La cells by trans-activation deficient p53. Genes Dev 17:2170-2183.
26. Pillai MR, Jayaprakash PG, Nair MK 1999 BCl-2 immunoreactivity but not p53 accumulation associated with early tumor response to radiotherapy in cervical carcinoma. J Cancer Res Clin Oncol 125:55-60.
27. Pillai MR, Jayaprakash PG, Nair MK 2000 Development of a cell kinetic model for the assessment of cervical carcinoma. In: Tatsuzaki H (ed) Radiation Responsiveness Criteria for Human Tumors as a Determinant for Therapeutic Modality Planning. International Atomic Energy Agency, Vienna.
28. Srinivas G, Kusumakumary P, Nair MK, Panicker KR, Pillai MR 1998 Bcl-2 protein and apoptosis in pediatric acute lymphoblastic leukemia. Int J Mol Med 1:755-759.